Study of the gastroenteropancreatic neuroendocrine tumor (gep-net) microenvironment beyond angiogenesis: The role of lysyl oxidase-like 2 (LOXL2).

被引:0
|
作者
Barriuso, Jorge
Bernal, Elsa
Pastrian, Laura Guerra
Grande, Enrique
Castellano, Daniel E.
Capdevila, Jaume
Alvarez-Escola, Cristina
Martinez, Jaime
Diaz, Esther
Heredia, Victoria
Castell, Jose
Feliu, Jaime
Burgos, Emilio
Mendiola, Marta
机构
[1] Univ Manchester, Fac Life Sci, La Paz Univ Hosp IdiPAZ, Translat Oncol & Pathol Grp,Mol Canc Grp, Manchester, Lancs, England
[2] La Paz Univ Hosp, Dept Med Oncol, Madrid, Spain
[3] La Paz Univ Hosp, Dept Pathol, Madrid, Spain
[4] Hosp Univ Ramon & Cajal, Dept Med Oncol, Madrid, Spain
[5] Hosp Univ 12 Octubre, Madrid, Spain
[6] Vall dHebron Univ Hosp, Barcelona, Spain
[7] La Paz Univ Hosp, Dept Endocrinol, Madrid, Spain
[8] La Paz Univ Hosp IdiPAZ, Translat Oncol & Pathol Group, Madrid, Spain
[9] La Paz Univ Hosp, Gastrointestinal Surg Dept, Madrid, Spain
关键词
D O I
10.1200/jco.2014.32.15_suppl.4109
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4109
引用
收藏
页数:1
相关论文
共 50 条
  • [1] External validation of lysyl oxidase-like 2 (LOXL2) as a novel prognostic marker for gastro-entero-pancreatic neuroendocrine tumors (GEP-NET)
    Barriuso, Jorge
    Benavent, Marta
    Lamarca, Angela
    Bernal, Elsa
    Pastrian, Laura Guerra
    Heredia, Victoria
    Miguel, Maria
    Garcia-Calderon, Clara Beatriz
    Alvarez-Escola, Cristina
    Castell, Jose
    Custodio, Ana
    Burgos, Emilio
    Feliu, Jaime
    Garcia-Carbonero, Rocio
    Mendiola, Marta
    CANCER RESEARCH, 2016, 76
  • [2] Evaluation of Lysyl Oxidase-Like-2 (LOXL2) Expression by Immunohistochemistry (IHC) in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET): A Retrospective Analysis and Comparison with PTEN
    Barriuso, J.
    Bernal, E.
    Pastrian, L.
    Alvarez-Escola, C.
    Martinez, J.
    Diaz, E.
    Castell, J.
    Feliu, J.
    Burgos, E.
    Mendiola, M.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 251 - 252
  • [3] Validation of Lysyl Oxidase-Like 2 (LOXL2) as Prognostic Marker for Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NET) Using an Independent Cohort
    Barriuso, J.
    Benavent, M.
    Lamarca, A.
    Bernal, E.
    Guerra-Pastrian, L.
    Heredia, V
    Miguel, M.
    Garcia-Calderon, C. B.
    Alvarez-Escola, C.
    Castell, J.
    Custodio, A.
    Burgos, E.
    Feliu, J.
    Carbonero R, Garcia
    Mendiola, M.
    NEUROENDOCRINOLOGY, 2016, 103 : 44 - 44
  • [4] LYSYL OXIDASE (LOX) AND LYSYL OXIDASE-LIKE 2 (LOXL2) CONTRIBUTE TO CARTILAGE CALCIFICATION DURING OSTEOARTHRITIS
    Faure, E.
    Bernabei, I.
    Wegrzyn, J.
    Hugle, T.
    Busso, N.
    Nasi, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 456 - 456
  • [5] Lysyl oxidase ( LOX) and lysyl oxidase-like 2 (LOXL2) contribute to cartilage calcification during osteoarthritis
    Faure, E.
    Bernabei, I
    Wegrzyn, J.
    Hugle, T.
    Busso, N.
    Nasi, S.
    SWISS MEDICAL WEEKLY, 2024, 154 : 17S - 17S
  • [6] Lysyl oxidase-like 2 (LOXL2)-mediated cross-linking of tropoelastin
    Schmelzer, Christian E. H.
    Heinz, Andrea
    Troilo, Helen
    Lockhart-Cairns, Michael P.
    Jowitt, Thomas A.
    Marchand, Marion F.
    Bidault, Laurent
    Bignon, Marine
    Hedtke, Tobias
    Barret, Alain
    McConnell, James C.
    Sherratt, Michael J.
    Germain, Stephane
    Hulmes, David J. S.
    Baldock, Clair
    Muller, Laurent
    FASEB JOURNAL, 2019, 33 (04): : 5468 - 5481
  • [7] Reaction mechanism of lysyl oxidase-like 2 (LOXL2) studied by computational methods
    Dong, Geng
    Lin, Li-Rui
    Xu, Li-Yan
    Li, En-Min
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2020, 211
  • [8] Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX
    Hutchinson, John H.
    Rowbottom, Martin W.
    Lonergan, David
    Darlington, Janice
    Prodanovich, Pat
    King, Christopher D.
    Evans, Jilly F.
    Bain, Gretchen
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (04): : 423 - 427
  • [9] Regulation of Epithelial Plasticity and Metastasis of Breast Carcinoma by Lysyl Oxidase-like 2 (LOXL2)
    Cano, A.
    Moreno-Bueno, G.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S23 - S23
  • [10] Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer
    Salvador, Fernando
    Martin, Alberto
    Lopez-Menendez, Celia
    Moreno-Bueno, Gema
    Santos, Vanesa
    Vazquez-Naharro, Alberto
    Santamaria, Patricia G.
    Morales, Saleta
    Dubus, Pierre R.
    Muinelo-Romay, Laura
    Lopez-Lopez, Rafael
    Tung, Jason C.
    Weaver, Valerie M.
    Portillo, Francisco
    Cano, Amparo
    CANCER RESEARCH, 2017, 77 (21) : 5846 - 5859